×
App Icon
The Standard e-Paper
Smart Minds Choose Us
★★★★ - on Play Store
Download App

Britain secures 60 million doses of Sanofi/GSK Covid-19 vaccine

Small bottles labelled with "Vaccine" stickers seen near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. [Photo:REUTERS]

Britain has signed a deal for up to 60 million doses of a possible Covid-19 vaccine being developed by Sanofi and GlaxoSmithKline it said on Wednesday, its fourth such arrangement as the race to tame the pandemic heats up.

No vaccine has yet been approved for Covid-19, the respiratory disease caused by the new coronavirus that has killed more than 659,000 people and unleashed economic havoc worldwide.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902